Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from PCI Biotech Holding ASA ( (DE:4QG) ) is now available.
PCI Biotech Holding ASA has announced the discontinuation of its photochemical lysis technology development due to insufficient progress and increased project risks. The company is now prioritizing value preservation and evaluating future options, including potential sale or merger, amid significant financial uncertainty.
More about PCI Biotech Holding ASA
PCI Biotech Holding ASA operates in the biotechnology industry, focusing on the development of photochemical lysis technology for viral vector manufacturing.
YTD Price Performance: 25.84%
Average Trading Volume: 42,340
Current Market Cap: NOK55.8M
Find detailed analytics on 4QG stock on TipRanks’ Stock Analysis page.